Advertisement
Canada markets close in 4 hours 57 minutes
  • S&P/TSX

    21,743.91
    -129.81 (-0.59%)
     
  • S&P 500

    5,006.19
    -65.44 (-1.29%)
     
  • DOW

    37,810.33
    -650.59 (-1.69%)
     
  • CAD/USD

    0.7297
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    82.11
    -0.70 (-0.85%)
     
  • Bitcoin CAD

    86,947.93
    -2,396.11 (-2.68%)
     
  • CMC Crypto 200

    1,373.46
    -9.12 (-0.66%)
     
  • GOLD FUTURES

    2,349.40
    +11.00 (+0.47%)
     
  • RUSSELL 2000

    1,966.24
    -29.19 (-1.46%)
     
  • 10-Yr Bond

    4.7140
    +0.0620 (+1.33%)
     
  • NASDAQ

    15,456.44
    -256.31 (-1.63%)
     
  • VOLATILITY

    17.05
    +1.08 (+6.77%)
     
  • FTSE

    8,063.67
    +23.29 (+0.29%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6808
    -0.0011 (-0.16%)
     

Will Clinical Trial Firm Icon Pass This Market Test?

Despite last week's sell-off on the Nasdaq and S&P 500, Ireland-based contract research organization (CRO) Icon has found support and shown resilience. Icon provides phase I - phase IV clinical trial services to pharmaceutical, biotech and medical device companies.